Comate Biosciences

科迈生物

Comate Biosciences

Biotech/Healthcare

A biotechnology company focused on early-stage antibody drug discovery. Jointly established by XtalPi and Biocytogen in June 2021, it has built and experimentally validated the industry's first data-driven AI platform for de novo, epitope-specific antibody design using proprietary, high-quality…

Latest round: Pre-Seed Extension (2026)

Source: ChinaBulls — chinabulls.com

Last updated 2026-03-01